There are 511 resources available
214P - A multicenter retrospective study of ramucirumab-containing chemotherapy for gastrointestinal neuroendocrine carcinoma after platinum-based chemotherapy (WJOG13420G: RAM-NEC)
Presenter: Yuki Matsubara
Session: Poster Display session
Resources:
Abstract
215P - Peptide receptor radionuclide therapy versus capecitabine/temozolomide for the treatment of metastatic pancreatic neuroendocrine tumors
Presenter: Rushabh Gujarathi
Session: Poster Display session
Resources:
Abstract
217P - Less frequent radiological response assessment to reduce costs from 177-LuDOTATE therapy for patients with advanced neuroendocrine tumors
Presenter: Carolina Marques
Session: Poster Display session
Resources:
Abstract
218P - Systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
Presenter: Eduardo Terán Brage
Session: Poster Display session
Resources:
Abstract
219P - Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-Dotatate (Lutathera) (LU) in neuroendocrine tumors (NETs)
Presenter: Pablo Reguera Puertas
Session: Poster Display session
Resources:
Abstract
220P - Treatment outcomes of amrubicin monotherapy for patients with advanced hepatobiliary and pancreatic neuroendocrine carcinoma
Presenter: Kanae Inoue
Session: Poster Display session
Resources:
Abstract
221P - TEMCAP regimen as first-line therapy in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) at a Latin American reference center: A ten-year follow-up study
Presenter: wagner cruz diaz
Session: Poster Display session
Resources:
Abstract
222P - Treatment modalities in pancreatic neuroendocrine tumors: A survival analysis from SEER database
Presenter: lana amouri
Session: Poster Display session
Resources:
Abstract
223P - Navigating neuroendocrine tumors: Insights from oncologists in Mexico
Presenter: Julieta Gómez
Session: Poster Display session
Resources:
Abstract
224P - Genomic patterns and clinical implications in gastroenteropancreatic neuroendocrine neoplasms
Presenter: Gordon Moffat
Session: Poster Display session
Resources:
Abstract